*  HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B - Full Text View - ClinicalTrials.gov
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... Aim 2: Clinical hepatitis flares during chronic hepatitis B reflect altered balance between immune regulatory and effector ... HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B. This study is ongoing, but not recruiting ... Aim 1: The clinical and virological status of chronic Hepatitis B (HBV) infection is defined by distinct patterns of immune ...
  https://clinicaltrials.gov/show/NCT01298037
*  Treatment of a Patient with HBeAg-negative Chronic Hepatitis B | healthPlexus.net
... hepatitis B is now becoming established in countries where it was previously uncommon. Chronic hepatitis B infection is a ... Treatment of a Patient with HBeAg-negative Chronic Hepatitis B. Ian PUN, MD, Family Physician, Scarborough, Ontario with help ... Chronic hepatitis B is mostly an asymptomatic disease, therefore, serological and imaging tests should be used to identify, ... It is estimated that there are 350 million world wide carriers of the hepatitis B virus, mostly coming from Asia (Lai et al., ...
  https://www.healthplexus.net/article/treatment-patient-hbeag-negative-chronic-hepatitis-b
*  Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection [Abstract]
Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection Sheng-Tao Cheng1*, Ding Yuan2*, Yi Liu3, ... Methods/Results: Serum IL-35 in 72 chronic hepatitis B virus infection patients and 41 healthy control subjects were analyzed ... Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection. Int J Med Sci 2018; 15(2):188-194. doi: ... Backgrounds: As one of the major public health problems, the hepatitis B virus (HBV) infection would activate the immune system ...
  http://www.medsci.org/v15p0188
*  Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection
Keywords: Interleukin-35, Hepatitis B virus Introduction. Chronic hepatitis B virus infection is a major global health problem ... This study examined 72 cases chronic hepatitis B virus infection patients including 31 cases hepatitis B virus e antigen (HBeAg ... The serum IL-23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B. Liver ... 3. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration ...
  http://www.medsci.org/v15p0188.htm
*  Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B - Tabular...
Chronic Hepatitis B. Intervention ICMJE Drug: combination of lamivudine+adefovir vs entecavir Lamivudine 100 mg/day, Adefovir ... Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B. This study ... The aim of this study is to determine the most effective therapy for the patients with lamivudine resistant chronic hepatitis B ... Since we are planning to include lamivudine-resistant chronic hepatitis B patients regardless of HBeAg status, we assumed the ...
  https://clinicaltrials.gov/ct2/show/record/NCT00531167
*  Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept - Full Text View...
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis B Drug Information available for: Telbivudine Tenofovir Tenofovir ... Chronic Hepatitis B Drug: Telbivudine 600mg Drug: Tenofovir disoproxil fumarate 300mg Phase 4 ... Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept (Sebivo/Tyzeka) ...
  https://clinicaltrials.gov/show/NCT01379508
*  Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B - Full Text View - ClinicalTrials.gov
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... Chronic Hepatitis B e Antigen Positive Chronic Hepatitis B e Antigen Negative ... Chronic infection with the hepatitis B virus may lead to cirrhosis, liver disease, and cancer of the liver. There is no cure ... Chronic hepatitis B affects at least 1.5 million Americans and is a major cause of cirrhosis, end-stage liver disease and ...
  https://clinicaltrials.gov/ct2/show/NCT01581554?recr=Open&cond=%22Hepatitis+A%22&rank=15
*  Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine...
A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China. J Dig Dis ... Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on- ... Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. ... Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341: 1256-63. *CrossRef, ...
  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2011.04750.x/references
*  Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B - Tabular View ...
The goal of chronic hepatitis B (CHB) treatment is complete and permanent eradication of hepatitis B virus (HBV) from patient's ... Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B (TERESA). This ... Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B. ... Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B Who Have Achieved Serum HBV DNA ...
  https://clinicaltrials.gov/ct2/show/record/NCT01595685?term=hepatitis+b&recr=Open
*  Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure - Sun -...
High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B, Hepatitis Research and Treatment, 2014, 2014, 1. ... Entecavir Versus Lamivudine Therapy for Patients With Chronic Hepatitis B-Associated Liver Failure: A Meta-Analysis, Hepatitis ... Background and Aims: Chronic hepatitis B virus (HBV) infection is a major global health issue, and the prognosis of patients ... Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation, Clinical and Translational Gastroenterology, 2017, 8, 6, e104 ...
  http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2009.06089.x/abstract
*  Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B - Full Text...
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B (HBRN). The ... Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B. ... of entecavir followed by 40 weeks of both entecavir and peginterferon in the treatment of chronic hepatitis B in hepatitis B 'e ...
  https://clinicaltrials.gov/ct2/show/NCT01534611?recr=Open&cond=%22Hepatitis+A%22&rank=8
*  Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection - Full Text View...
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Virus Diseases. Liver Diseases. Digestive System ... MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis B Drug Information available for: Entecavir Tenofovir Tenofovir ... Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection. The safety and ... Patient who has a liver disease other than chronic hepatitis B (e.g. hemochromatosis, Wilson's disease, alcoholic liver disease ...
  https://clinicaltrials.gov/ct2/show/study/NCT01594905?view=results
*  Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a...
Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a ... Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a ... Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a ... therapy in treatment-naive chronic hepatitis B (CHB) patients and to determine whether continuous ETV therapy is feasible to ...
  https://www.docphin.com/research/article-detail/17611694/PubMedID-26100697/Prolonged-Entecavir-Therapy-Is-Not-Effective-for-HBeAg-Seroconversion-in-Treatment-Naive-Chronic-Hepatitis-B-Patients-with-a-Partial-Virological-Response
*  Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load - Full Text View - ClinicalTrials...
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load (LVL). The safety and scientific ... MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis B Drug Information available for: Formic acid Interferon Interferon ... Chronic Hepatitis B Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate ...
  https://clinicaltrials.gov/ct2/show/study/NCT00973219?view=record
*  Virologic breakthrough in a patient with chronic hepatitis B by combin | DDDT
Here, we report for the first time a patient with chronic hepatitis B and cirrhosis who emerged with virologic breakthrough ... A 51-year-old Japanese woman with hepatitis B e-antigen (HBeAg), whose genotype was C, received ETV monotherapy continuously ... of resistance selection during treatment with TDF in treatment-naïve and nucleoside/nucleotide analog-treated chronic hepatitis ... is widely used to treat hepatitis B virus (HBV) patients in the USA and Europe. No confirmed report ...
  https://www.dovepress.com/virologic-breakthrough-in-a-patient-with-chronic-hepatitis-b-by-combin-peer-reviewed-article-DDDT
*  Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B...
Hepatitis. Hepatitis A. Hepatitis, Chronic. Hepatitis B. Hepatitis B, Chronic. Liver Diseases. Digestive System Diseases. ... hepatitis B. HBe negative. HBV vaccination. entecavir. tenofovir. chronic hepatitis. immune specific responses to HBV. phase 1/ ... Chronic Hepatitis B Drug: CYT107+GenHevac+entecavir or tenofovir Drug: CYT107+ entecavir or tenofovir Phase 1 Phase 2 ... Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B ...
  https://clinicaltrials.gov/ct2/show/study/NCT01027065?view=results
*  Safety and immunogenicity study of nivolumab with or without GS-4774 in patients with HBeAg negative chronic hepatitis B...
This exploratory study investigated nivolumab with or without GS-4774 in patients with HBeAg negative chronic hepatitis B ... Safety and immunogenicity study of nivolumab with or without GS-4774 in patients with HBeAg negative chronic hepatitis B ... Safety and immunogenicity study of nivolumab with or without GS-4774 in patients with HBeAg negative chronic hepatitis B ...
  http://adisinsight.springer.com/trials/700286596?error=cookies_not_supported&code=29935c9b-edc8-4671-9224-ab91554930a9
*  WHO | Hepatitis C
... the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to ... Hepatitis C is a liver disease caused by the hepatitis C virus: ... Hepatitis C virus (HCV) causes both acute and chronic infection ... Hepatitis C is a liver disease caused by the hepatitis C virus: the virus can cause both acute and chronic hepatitis, ranging ... In April 2016, WHO updated its "Guidelines for the screening, care and treatment of persons with chronic hepatitis C". These ...
  http://www.who.int/mediacentre/factsheets/fs164/en/
*  HEPATITIS CHRONIC PANEL
Hepatitis B Surface Antibody: 86706, Hepatitis B Surface Antigen: 87340, Hepatitis B Core Antibody, Total: 86704, Hepatitis C ... Hepatitis B Surface Antigen; Hepatitis B Core Total Antibody; Hepatitis B Surface Antibody; Hepatitis C Antibody ... Home : For health professionals : Refer a patient : Laboratory Services : Test Table : HEPATITIS CHRONIC PANEL ... Reactive Hepatitis B Surface Antigen will reflex to the Hepatitis B Surface Antigen Confirmatory neutralization test for an ...
  http://www.legacyhealth.org/for-health-professionals/refer-a-patient/laboratory-services/test-table/hepatitis-chronic-panel.aspx
*  Search of: 'Hepatitis, Chronic' - Modify Search - ClinicalTrials.gov
Search of: 'Hepatitis, Chronic' - Modify Search. Fill in any or all of the fields below. Click on the label to the left of each ...
  https://clinicaltrials.gov/ct2/results/refine?cond=%22Hepatitis%2C+Chronic%22
*  One in 100 Americans has chronic hepatitis C infection | Reuters
At least one percent of Americans are chronically infected with the hepatitis C virus, which over time ca ... who face a prevalence of chronic hepatitis C infection six times greater than other adults, should get tested at least once for ... found about 2.7 million people have chronic hepatitis C infection," he added. ... Chronic HCV is typically treated with combinations of anti-viral drugs. "One finding of (this new) study was that only half of ...
  http://www.reuters.com/article/us-chronic-hepatitisc/one-in-100-americans-has-chronic-hepatitis-c-infection-idUSBREA261PJ20140307?feedType=RSS
*  Diagnosis and evaluation of chronic hepatitis C virus infection
Serologic assays that detect antibodies to hepatitis CMolecular assays that detect or quantify HCV RNAOther investigations such ... Diagnostic tests for hepatitis C virus (HCV) can be divided into two broad categories: ... Diagnostic tests for hepatitis C. Hepatology 1997; 26:43S.. *Kao JH, Lai MY, Hwang YT, et al. Chronic hepatitis C without anti- ... Patient education: Hepatitis C (The Basics). *Patient evaluation and selection for antiviral therapy for chronic hepatitis C ...
  http://www.uptodate.com/contents/diagnosis-and-evaluation-of-chronic-hepatitis-c-virus-infection
*  Antineutrophil Cytoplasmic Antibody Frequency in Chronic Hepatitis B Patients
... Turan Calhan,1 Abdurrahman Sahin,1 Resul ... Turan Calhan, Abdurrahman Sahin, Resul Kahraman, et al., "Antineutrophil Cytoplasmic Antibody Frequency in Chronic Hepatitis B ...
  https://www.hindawi.com/journals/dm/2014/982150/cta/
*  Epclusa Approved for Chronic Hepatitis C - Drugs.com MedNews
Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV). Epclu ... Epclusa Approved for Chronic Hepatitis C. Print this page TUESDAY, June 28, 2016 -- The combination drug Epclusa has been ... Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV). ... For people with moderate-to-severe cirrhosis (chronic liver disease), Epclusa is approved to be used in combination with the ...
  https://www.drugs.com/news/epclusa-approved-chronic-hepatitis-c-61767.html
*  chronic hepatitis C - Forum on Opportunistic Infections - TheBody.com
The only way to estimate the duration of chronic hepatitis C is to do a liver biopsy. If there is fibrosis (scarring) or ... chronic hepatitis C. Jul 17, 2001 I've been diagnosed with Hepatitis C. Is there a procedure that can determine wheather the ... The only way to estimate the duration of chronic hepatitis C is to do a liver biopsy. If there is fibrosis (scarring) or ... Visit the Forum on Hepatitis and HIV Coinfection Browse Forums: <-- Select -->. Aging. Choosing Your Meds. En Español. In ...
  http://www.thebody.com/Forums/AIDS/Infections/Q49117.html